Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Recent Auspex patent discloses new treatment option for substance abuse and dependence

July 6, 2007

Positive phase I/II results for ALKS-29 in alcohol-dependent patients

July 4, 2007

New agents for substance abuse imparted in recent Auspex patent

June 25, 2007

NICE recommends use of Champix on U.K.'s National Health Service

June 1, 2007

Mucosal trivalent vaccine against botulism toxin identified at DOR BioPharma

May 31, 2007

NT69L and LY-379268 studied for possible use in nicotine addiction

May 29, 2007

Exjade labeling receives new Warning and Adverse Reactions information

May 28, 2007

Nalmefene licensing agreement enters into force

May 25, 2007

AEOL-10150 to be studied in mustard gas-mediated lung injury

May 25, 2007

Novartis in-licenses CYT002-NicQb for treatment of nicotine addiction

April 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...